JO2730B1 - Medications for the treatment of endometriosis - Google Patents

Medications for the treatment of endometriosis

Info

Publication number
JO2730B1
JO2730B1 JO200833A JOP20080033A JO2730B1 JO 2730 B1 JO2730 B1 JO 2730B1 JO 200833 A JO200833 A JO 200833A JO P20080033 A JOP20080033 A JO P20080033A JO 2730 B1 JO2730 B1 JO 2730B1
Authority
JO
Jordan
Prior art keywords
endometriosis
medicament
treatment
prevention
manufacture
Prior art date
Application number
JO200833A
Other languages
Arabic (ar)
English (en)
Inventor
بيليسير - مارتينز انطونيو
Original Assignee
فيرنج انترناشونال سنتر اس ايه
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07250429A external-priority patent/EP1952813A1/en
Priority claimed from GB0712626A external-priority patent/GB2450533A/en
Application filed by فيرنج انترناشونال سنتر اس ايه filed Critical فيرنج انترناشونال سنتر اس ايه
Application granted granted Critical
Publication of JO2730B1 publication Critical patent/JO2730B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JO200833A 2007-02-01 2008-02-02 Medications for the treatment of endometriosis JO2730B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07250429A EP1952813A1 (en) 2007-02-01 2007-02-01 Medicament for the treatment of endometriosis
GB0712626A GB2450533A (en) 2007-06-29 2007-06-29 Treatment and prevention of endometriosis using dopamine agonists.

Publications (1)

Publication Number Publication Date
JO2730B1 true JO2730B1 (en) 2013-09-15

Family

ID=39674574

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200833A JO2730B1 (en) 2007-02-01 2008-02-02 Medications for the treatment of endometriosis

Country Status (20)

Country Link
US (2) US8927568B2 (enExample)
EP (1) EP2109449B1 (enExample)
JP (1) JP5211073B2 (enExample)
AR (1) AR065139A1 (enExample)
AT (1) ATE516805T1 (enExample)
AU (1) AU2008211633B2 (enExample)
BR (1) BRPI0806944A2 (enExample)
CA (1) CA2676910C (enExample)
DK (1) DK2109449T3 (enExample)
IL (1) IL200032A (enExample)
JO (1) JO2730B1 (enExample)
MX (1) MX2009008191A (enExample)
NZ (1) NZ578569A (enExample)
PL (1) PL2109449T3 (enExample)
PT (1) PT2109449E (enExample)
RU (1) RU2423146C2 (enExample)
SA (1) SA08290041B1 (enExample)
SI (1) SI2109449T1 (enExample)
TW (1) TWI411436B (enExample)
WO (1) WO2008093247A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010150098A2 (en) * 2009-06-26 2010-12-29 Ferring International Center Sa Treatment of endometriosis
EP3017809A1 (en) 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
WO2017210117A1 (en) * 2016-06-02 2017-12-07 Board Of Trustees, Southern Illinois University Treatment of endometriosis and niclosamide derivatives
JP6562332B2 (ja) * 2017-05-30 2019-08-21 有限会社イムノ 活性化ｔ細胞からのｉｌ−８産生を抑制するための組成物
RU2732251C1 (ru) * 2019-11-29 2020-09-14 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ лечения наружного генитального эндометриоза
US20240361338A1 (en) 2021-08-31 2024-10-31 Ferring B.V. Diagnosis and treatment of ectopic endometriosis
WO2024153752A1 (en) 2023-01-20 2024-07-25 Ferring B.V. Stereoselective synthesis of intermediates and synthesis of quinagolids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208417A3 (en) * 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
WO1993003752A1 (en) * 1991-08-19 1993-03-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Decapeptide having dopamine stimulating activity
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6127401A (en) * 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
RU2273481C2 (ru) * 2004-05-27 2006-04-10 Варвара Анатольевна Волкова Способ повышения эффективности лечения бесплодия, вызванного малыми формами внешнего генитального эндометриоза
WO2006117608A1 (en) * 2005-04-29 2006-11-09 Ferring International Center S.A. Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist
WO2010150098A2 (en) * 2009-06-26 2010-12-29 Ferring International Center Sa Treatment of endometriosis

Also Published As

Publication number Publication date
HK1134911A1 (en) 2010-05-20
IL200032A0 (en) 2010-04-15
SI2109449T1 (sl) 2011-11-30
WO2008093247A2 (en) 2008-08-07
RU2009129252A (ru) 2011-03-10
US20150073010A1 (en) 2015-03-12
RU2423146C2 (ru) 2011-07-10
AU2008211633B2 (en) 2011-04-21
US9023862B2 (en) 2015-05-05
SA08290041B1 (ar) 2012-06-05
IL200032A (en) 2015-06-30
EP2109449B1 (en) 2011-07-20
JP5211073B2 (ja) 2013-06-12
PL2109449T3 (pl) 2011-12-30
AR065139A1 (es) 2009-05-20
AU2008211633A1 (en) 2008-08-07
PT2109449E (pt) 2011-11-02
US8927568B2 (en) 2015-01-06
BRPI0806944A2 (pt) 2014-05-06
CA2676910A1 (en) 2008-08-07
WO2008093247A3 (en) 2008-12-04
TW200845989A (en) 2008-12-01
ATE516805T1 (de) 2011-08-15
US20100113499A1 (en) 2010-05-06
DK2109449T3 (da) 2011-09-12
EP2109449A2 (en) 2009-10-21
MX2009008191A (es) 2009-08-12
NZ578569A (en) 2011-08-26
CA2676910C (en) 2012-01-03
JP2010517992A (ja) 2010-05-27
TWI411436B (zh) 2013-10-11

Similar Documents

Publication Publication Date Title
HUS1800011I1 (hu) Kombinációs terápia szubsztituált oxazolidinonokkal
PL2307079T3 (pl) Urządzenie do podawania leku
TN2012000082A1 (en) Use of nicotinic acetylcholine receptor alpha 7 activators
PL2240220T3 (pl) Wszczepialne urządzenia do podawania leków i aparaty do napełniania urządzeń
PL2058020T3 (pl) Urządzenie do podawania leków
EP2083781A4 (en) ADMINISTRATION DEVICE
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
EP2195010A4 (en) TREATMENT WITH INHIBITORS OF KALLIKREINE
ZA200809529B (en) Melatonin agonist treatment
IL194506A0 (en) Implants for the treatment of dopamine associated states
GB0700786D0 (en) Morpholine dopamine agonists for the treatment of pain
JO2730B1 (en) Medications for the treatment of endometriosis
PL1972724T3 (pl) Urządzenie do profilowania kanałów
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
EA201071412A1 (ru) Дронедарон для предотвращения кардиоверсии
GB0622418D0 (en) Vapour delivering device
WO2010150098A3 (en) Use of quingolide in the treatment of endometriosis, pain and cancer
GB0625783D0 (en) Medicament
ZA200904478B (en) Novel therapeutic use for treating leukaemia
EP2309856A4 (en) PHARMACEUTICAL COMPOUNDS AS CYTOTOXICA AND ITS APPLICATION
GB0615064D0 (en) Medicament
TWM292546U (en) Medicament counter
GB0712626D0 (en) Medicament for the treatment of endometriosis
UA27344U (en) Use of pollentar pharmaceutical composition as cerebroprotective agent
UA29770U (ru) Применение мигрепина как вещества с противоболевыми свойствами